Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

Oral Immunotherapy for Children With Cow's Milk Allergy

NCT07768696 · tracked via the Priya Life Science Denmark tracker
Sponsor
Laura Ozer Kettner
Phase
Not applicable
Started
2026-09
Last updated
2026-08-17

Condition(s) studied

Milk Allergy, Cow'sFood Allergy in ChildrenFood Allergies

Investigational drug(s) / intervention(s)

Oral immunotherapy with cow's milk

Oral immunotherapy with cow's milk: Oral immunotherapy with cow's milk for 1-1.5 years

Study summary

This clinical trial aims to investigate if oral immunotherapy can help children with cow's milk allergy tolerate cow's milk.

Children aged 6-18 months can take part in the trial.

Main question: What percentage of children can tolerate cow's milk after oral immunotherapy, compared with children who avoid cow's milk?

Children are assigned to these two groups by chance.

Children receiving oral immunotherapy will:

* Take a small, increasing amount of cow's milk daily for 1-1.5 years
* Attend clinic or online visits each time the dose is increased
* Record missed doses

All children will:

* Provide blood samples to measure allergy-related markers
* Undergo an oral food challenge with cow's milk after 1-1.5 years to assess how much they can tolerate
* Report allergic reactions (parent-reported)
* Complete questionnaires (parent-reported)
* Participate in an end-of-study telephone interview with an allergy nurse (parent-reported)

Eligibility

Sex
ALL
Min age
6 Months
Max age
18 Months
Healthy volunteers
No
Inclusion Criteria: * Aged 6 to 18 months * Cow's milk allergy confirmed at an oral food challenge * Reaction threshold below 300 mg of cow's milk protein at the oral food challenge * Specific IgE to cow's milk \> 0.35 kU/L * High risk of persistent allergy to cow's milk (based on defined criteria) * Family motivated for oral immunotherapy following shared decision-making using a decision aid Exclusion Criteria: * Uncontrolled asthma, eczema, rhino-conjunctivitis, urticaria, or eosinophilic esophagitis * Treatment with biologic or immunosuppressive medication * Non-Danish-speaking families * Anticipated non-adherent families

Primary outcome measure(s)

  • Tolerance to cow's milk (4000 mg) — 1-1.5 years after enrollment
    Proportion of children who tolerate a cumulative dose of 4343 mg of cow's milk protein at an oral food challenge

Trial sites (5)

FacilityCityRegionStatus
The Danish Center of Pediatric Pulmonology and Allergology, Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital Aarhus Denmark
Regional Hospital Gødstrup Gødstrup Denmark
Regional Hospital Kolding Kolding Denmark
Regional Hospital Randers Randers Denmark
Regional Hospital Viborg Viborg Denmark
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07768696 on ClinicalTrials.gov ↗ ← All trials in Denmark